Anthony Marucci
Net worth: 1 M $ as of 2026-05-30
Net worth: 1 M $ as of 2026-05-30
Mr. Anthony S.
Marucci is a President, CEO, CFO, Secretary, Treasurer & VP at Celldex Research Corp.
and a President, Chief Executive Officer & Director at Celldex Therapeutics, Inc. He is on the Board of Directors at BioNJ, Inc., Celldex Therapeutics, Inc., Celldex Therapeutics Ltd. and College of Business & Public Management.
Mr. Marucci was previously employed as an Independent Director by Genenta Science SpA, an Interim President & Chief Executive Officer by AVANT Immunotherapeutics, Inc., a Treasurer & Acting Chief Executive Officer by Celldex Therapeutics, Inc. (Old), a Treasurer by Medarex, Inc., and a President by CuraGen Corp.
He received his undergraduate degree from Kean University, a graduate degree from Brown University and an MBA from The Trustees of Columbia University in The City of New York.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-24 | 41,675 ( 0.05% ) | 1 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Founder | 1982-12-31 |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Director/Board Member | 2009-12-31 |
Celldex Therapeutics Ltd. | Director/Board Member | 2010-08-05 |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Chief Executive Officer | 2003-04-30 |
College of Business & Public Management | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | President | 2008-09-30 |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Treasurer | 2004-02-29 |
| GENENTA SCIENCE S.P.A. | Director/Board Member | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | President | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 13 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kean University
Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
Celldex Therapeutics Ltd. | |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
College of Business & Public Management |
Select your edition
All financial news and data tailored to specific country editions